ALSAF Fundamental Analysis - SAFE ORTHOPAEDICS SA

Fundamental Rating

Taking everything into account, ALSAF scores 1 out of 10 in our fundamental rating. ALSAF was compared to 68 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of ALSAF have multiple concerns. ALSAF has a expensive valuation and it also scores bad on growth.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALSAF had negative earnings in the past year.

ALSAF had a negative operating cash flow in the past year.

In the past 5 years ALSAF always reported negative net income.

In the past 5 years ALSAF reported 4 times negative operating cash flow.

1.2 Ratios

ALSAF has a worse Return On Assets (-22350.40%) than 95.59% of its industry peers.

		Industry Rank	Sector Rank
ROA	-22350.4%
ROE	N/A
ROIC	N/A

ROA(3y)-5930.98%

ROA(5y)-3579.18%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 50.80%, ALSAF is doing worse than 61.76% of the companies in the same industry.

In the last couple of years the Gross Margin of ALSAF has grown nicely.

ALSAF does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	50.8%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-2.39%

GM growth 5Y14.07%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALSAF does not have a ROIC to compare to the WACC, probably because it is not profitable.

Compared to 1 year ago, ALSAF has more shares outstanding

ALSAF has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, ALSAF has an improved debt to assets ratio.

2.2 Solvency

ALSAF has an Altman-Z score of -13.39. This is a bad value and indicates that ALSAF is not financially healthy and even has some risk of bankruptcy.

With a Altman-Z score value of -13.39, ALSAF is not doing good in the industry: 86.76% of the companies in the same industry are doing better.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-13.39

ROIC/WACCN/A

WACC3.69%

2.3 Liquidity

ALSAF has a Current Ratio of 0.20. This is a bad value and indicates that ALSAF is not financially healthy enough and could expect problems in meeting its short term obligations.

ALSAF has a Current ratio of 0.20. This is amonst the worse of the industry: ALSAF underperforms 95.59% of its industry peers.

ALSAF has a Quick Ratio of 0.20. This is a bad value and indicates that ALSAF is not financially healthy enough and could expect problems in meeting its short term obligations.

ALSAF's Quick ratio of 0.04 is on the low side compared to the rest of the industry. ALSAF is outperformed by 95.59% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.2
Quick Ratio	0.04

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 99.51% over the past year.

The Revenue for ALSAF has decreased by -13.24% in the past year. This is quite bad

ALSAF shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.42% yearly.

EPS 1Y (TTM)99.51%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%99.87%

Revenue 1Y (TTM)-13.24%

Revenue growth 3Y3.44%

Revenue growth 5Y1.42%

Sales Q2Q%-3.07%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y14.29%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year11.69%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

ALSAF reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALSAF. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ALSAF!.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

SAFE ORTHOPAEDICS SA

EPA:ALSAF (1/13/2026, 7:00:00 PM)

1.1

0 (0%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupHealth Care Equipment & Services

GICS IndustryHealth Care Equipment & Supplies

Earnings (Last)06-30 2025-06-30

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap198.00K

Revenue(TTM)4.96M

Net Income(TTM)-1.77B

Analysts40

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.04
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-229246.54

EYN/A

EPS(NY)-0.06

Fwd EYN/A

FCF(TTM)-20.41

FCFYN/A

OCF(TTM)-19.92

OCFYN/A

SpS27.56

BVpS-87.23

TBVpS-88.67

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-22350.4%
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	50.8%
FCFM	N/A

ROA(3y)-5930.98%

ROA(5y)-3579.18%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-2.39%

GM growth 5Y14.07%

F-Score3

Asset Turnover0.62

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	N/A
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.2
Quick Ratio	0.04
Altman-Z	-13.39

F-Score3

WACC3.69%

ROIC/WACCN/A

Cap/Depr(3y)39.29%

Cap/Depr(5y)87.91%

Cap/Sales(3y)5.82%

Cap/Sales(5y)15.08%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)99.51%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%99.87%

EPS Next Y14.29%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-13.24%

Revenue growth 3Y3.44%

Revenue growth 5Y1.42%

Sales Q2Q%-3.07%

Revenue Next Year11.69%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y63.68%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year7.84%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-105.19%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-105.05%

OCF growth 3YN/A

OCF growth 5YN/A

SAFE ORTHOPAEDICS SA / ALSAF.PA FAQ

What is the fundamental rating for ALSAF stock?

ChartMill assigns a fundamental rating of 1 / 10 to ALSAF.PA.

Can you provide the valuation status for SAFE ORTHOPAEDICS SA?

ChartMill assigns a valuation rating of 0 / 10 to SAFE ORTHOPAEDICS SA (ALSAF.PA). This can be considered as Overvalued.

Can you provide the profitability details for SAFE ORTHOPAEDICS SA?

SAFE ORTHOPAEDICS SA (ALSAF.PA) has a profitability rating of 1 / 10.

What is the earnings growth outlook for SAFE ORTHOPAEDICS SA?

The Earnings per Share (EPS) of SAFE ORTHOPAEDICS SA (ALSAF.PA) is expected to grow by 14.29% in the next year.

SAFE ORTHOPAEDICS SA (ALSAF.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

SAFE ORTHOPAEDICS SA / ALSAF.PA FAQ

What is the fundamental rating for ALSAF stock?

Can you provide the valuation status for SAFE ORTHOPAEDICS SA?

Can you provide the profitability details for SAFE ORTHOPAEDICS SA?

What is the earnings growth outlook for SAFE ORTHOPAEDICS SA?